Moira McMahon REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 MOIRA MCMAHON, Johns Hopkins University, Baltimore The hepatitis B drug ente
Moira McMahon
REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007MOIRA MCMAHON, Johns Hopkins University, BaltimoreThe hepatitis B drug entecavir appears to select for a drug resistant HIV mutation – and this has implications for patients infected with both viruses. Derek Thorne got the details fromMoira McMahonfrom Johns Hopkins University in Baltimore. .